What NIRAMAI Health Analytix does
NIRAMAI Health Analytix develops an AI-based medical device for early breast cancer detection. Its Thermalytix solution uses thermal imaging combined with machine learning to identify breast abnormalities, offering a screening method that is radiation-free, non-invasive, and portable.
Key capabilities
Thermalytix analyzes thermal images with AI algorithms to detect abnormalities at earlier stages. The approach is contactless and painless, requires no incisions or radiation, and works independent of age or breast density across a wide age range. NIRAMAI positions it as affordable and portable enough to deploy in clinics, hospitals, and community outreach programs.
Who it's for
NIRAMAI's technology is intended for women across a broad age range and for healthcare providers and screening programs seeking accessible early breast cancer detection. Its privacy-aware, portable design makes it suitable for outreach and resource-limited settings as well as conventional clinical use.